AAM
Austin Asset Management Portfolio holdings
AUM
$513M
This Quarter Return
+10.28%
1 Year Return
+13.38%
3 Year Return
+70.11%
5 Year Return
–
10 Year Return
–
AUM
$380M
AUM Growth
+$380M
(+11%)
Cap. Flow
+$2.59M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
83.41%
Holding
64
New
3
Increased
17
Reduced
21
Closed
6
Top Buys
| 1 |
Atlas Energy Solutions
AESI
|
$2.71M |
| 2 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
$1.68M |
| 3 |
Dimensional US Core Equity 2 ETF
DFAC
|
$1.21M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
$1.05M |
| 5 |
Avantis International Equity ETF
AVDE
|
$1.01M |
Top Sells
| 1 |
CDW
CDW
|
$3.37M |
| 2 |
Dimensional US Equity ETF
DFUS
|
$1.01M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
$780K |
| 4 |
First Financial Bankshares
FFIN
|
$455K |
| 5 |
Dimensional US Small Cap ETF
DFAS
|
$340K |
Sector Composition
| 1 | Financials | 5.38% |
| 2 | Technology | 1.89% |
| 3 | Energy | 0.85% |
| 4 | Industrials | 0.64% |
| 5 | Consumer Discretionary | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $286K | 0.08% |
5,979
| – | – |
|
52
Alphabet (Google) Class C
GOOG
$2.58T
| $286K | 0.08% |
2,032
-20
| -1% | -$2.82K |
|
53
iShares TIPS Bond ETF
TIP
$13.6B
| $281K | 0.07% |
+2,617
| New | +$281K |
|
54
Procter & Gamble
PG
$368B
| $272K | 0.07% |
1,859
-234
| -11% | -$34.3K |
|
55
Atlassian
TEAM
$46.6B
| $267K | 0.07% |
1,123
| – | – |
|
56
Johnson & Johnson
JNJ
$427B
| $262K | 0.07% |
1,670
-51
| -3% | -$7.99K |
|
57
NVIDIA
NVDA
$4.24T
| $236K | 0.06% |
476
| – | – |
|
58
Avantis US Large Cap Value ETF
AVLV
$8.17B
| $229K | 0.06% |
+3,957
| New | +$229K |
|
59
Avantis Short-Term Fixed Income ETF
AVSF
$668M
| – | – |
-6,300
| Closed | -$287K |
|
60
SPDR Bloomberg Barclays International Treasury Bond ETF
BWX
$1.38B
| – | – |
-13,490
| Closed | -$287K |
|
|
61
CDW
CDW
$21.6B
| – | – |
-16,700
| Closed | -$3.37M |
|
62
iShares Core MSCI Total International Stock ETF
IXUS
$47.8B
| – | – |
-4,090
| Closed | -$245K |
|
63
Merck
MRK
$210B
| – | – |
-2,508
| Closed | -$258K |
|
64
Pfizer
PFE
$141B
| – | – |
-6,742
| Closed | -$224K |
|